McKesson Corporation
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.
Headquarters in Irving, Texas | |
| Formerly |
|
|---|---|
| Company type | Public |
| Industry | Healthcare |
| Founded | New York City, United States 1833 |
| Founders |
|
| Headquarters | , United States |
Key people | Brian S. Tyler (CEO) |
| Products | |
| Revenue | US$276.71 billion (2023): 70 |
| US$4.38 billion (2023): 70 | |
| US$3.56 billion (2023): 70 | |
| Total assets | US$62.32 billion (2023): 72 |
| Total equity | US$−1.49 billion (2023): 72 |
Number of employees | c. 51,000 (2023): 9 |
| Subsidiaries | |
| Website | McKesson.com |
McKesson is based in Irving, Texas, and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the U.S. government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over 1 billion doses across the United States.
As of 2023, McKesson was ranked #9 on the Fortune 500 rankings of the largest United States corporations. As of 2023, they had revenues of $276 billion.